BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2932202)

  • 1. Differential alterations in opioid analgesia following neonatal monosodium glutamate treatment.
    Bodnar RJ; Portzline T; Nilaver G
    Brain Res Bull; 1985 Sep; 15(3):299-305. PubMed ID: 2932202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective potentiations in opioid analgesia following scopolamine pretreatment.
    Sperber ES; Romero MT; Bodnar RJ
    Psychopharmacology (Berl); 1986; 89(2):175-6. PubMed ID: 2941816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal monosodium glutamate. Effects upon analgesic responsivity and immunocytochemical ACTH/beta-lipotropin.
    Bodnar RJ; Abrams GM; Zimmerman EA; Krieger DT; Nicholson G; Kizer JS
    Neuroendocrinology; 1980 May; 30(5):280-4. PubMed ID: 6247667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in delta, but not mu, receptors in MSG-treated rats.
    Young E; Olney J; Akil H
    Life Sci; 1982 Sep 20-27; 31(12-13):1343-6. PubMed ID: 6292627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-mediated cardiovascular effects of clonidine in spontaneously hypertensive rats: elimination by neonatal treatment with monosodium glutamate.
    Mosqueda-Garcia R; Eskay R; Zamir N; Palkovits M; Kunos G
    Endocrinology; 1986 May; 118(5):1814-22. PubMed ID: 2938932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of opioid and nonopioid analgesic responses following adult monosodium glutamate pretreatment.
    Sathaye N; Bodnar RJ
    Physiol Behav; 1989 Aug; 46(2):217-22. PubMed ID: 2602462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of vasopressin analgesia in rats treated neonatally with monosodium glutamate.
    Bodnar RJ; Truesdell LS; Nilaver G
    Peptides; 1985; 6(4):621-6. PubMed ID: 4070021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG.
    Romagnano MA; Chafel TL; Pilcher WH; Joseph SA
    Brain Res; 1982 Mar; 236(2):497-504. PubMed ID: 7039767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of morphine hyperphagia following neonatal monosodium glutamate treatment in rats.
    Bodnar RJ; Mann PE; Romero MT; Truesdell LS
    Life Sci; 1986 Mar; 38(10):947-50. PubMed ID: 3951319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments in analgesic, hypothermic, and glucoprivic stress responses following neonatal monosodium glutamate.
    Badillo-Martinez D; Nicotera N; Butler PD; Kirchgessner AL; Bodnar RJ
    Neuroendocrinology; 1984 Jun; 38(6):438-46. PubMed ID: 6738808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective alterations of opiate receptor subtypes in monosodium glutamate-treated rats.
    Young E; Olney J; Akil H
    J Neurochem; 1983 Jun; 40(6):1558-64. PubMed ID: 6304248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neonatal treatment with monosodium glutamate on vasopressin release during foot shock stress in the rat.
    Knepel W; Nutto D; Hertting G
    Life Sci; 1983 Oct; 33(17):1703-9. PubMed ID: 6314081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neonatal treatment with monosodium glutamate on the secretion of alpha-MSH, beta-endorphin and ACTH in the rat.
    Conte-Devolx B; Giraud P; Castanas E; Boudouresque F; Orlando M; Gillioz P; Oliver C
    Neuroendocrinology; 1981; 33(4):207-11. PubMed ID: 6270587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naloxone and neonatal treatment with monosodium-L-glutamate on growth hormone and prolactin release induced by electrical stimulation of the medial-basal hypothalamus in rats.
    Antoni FA; Kanyicska B; Makara GB
    J Endocrinol; 1983 Mar; 96(3):427-32. PubMed ID: 6833931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monosodium glutamate-induced reductions in hypothalamic beta-endorphin content result in mu-opioid receptor upregulation in the medial preoptic area.
    Desjardins GC; Brawer JR; Beaudet A
    Neuroendocrinology; 1992 Sep; 56(3):378-84. PubMed ID: 1331839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monosodium glutamate and analgesia induced by morphine. Test-specific effects.
    Badillo-Martinez D; Kirchgessner AL; Butler PD; Bodnar RJ
    Neuropharmacology; 1984 Oct; 23(10):1141-9. PubMed ID: 6521850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of stress-induced prolactin release in monosodium glutamate-treated rats.
    Mizunuma H; Khorram O; McCann SM
    Brain Res Bull; 1983 Jan; 10(1):23-6. PubMed ID: 6297690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla.
    Alessi NE; Quinlan P; Khachaturian H
    Peptides; 1988; 9(4):689-95. PubMed ID: 2852357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal monosodium glutamate lesions alter neurosensitivity to ethanol in adult mice.
    Crabbe JC; Dorsa DM
    Pharmacol Biochem Behav; 1986 May; 24(5):1343-51. PubMed ID: 2941768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to anesthetic stress and beta-endorphin is altered in female rats treated neonatally with monosodium glutamate.
    Clough RW; Aravich PF; Phelps CJ
    Neuropeptides; 1992 Jun; 22(2):129-35. PubMed ID: 1407411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.